References
Fawcett K, Mehrabian M, Liu YT, Hamed S, Elahi E, Revesz T, Koutsis G, Herscheson J, Schottlaender L, Wardle M, Morrison PJ, Morris HR, Giunti P, Wood N, Houlden H (2012) The frequency of spinocerebellar ataxia type 23 in a UK population. J Neurol. doi:10.1007/s00415-012-6721-1
Bakalkin G, Watanabe H, Jezierska J, Depoorter C, Verschuuren-Bemelmans C, Bazov I, Artemenko KA, Yakovleva T, Dooijes D, Van de Warrenburg BP, Zubarev RA, Kremer B, Knapp PE, Hauser KF, Wijmenga C, Nyberg F, Sinke RJ, Verbeek DS (2010) Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet 87(5):593–603. doi:10.1016/j.ajhg.2010.10.001
Schicks J, Synofzik M, Beetz C, Schiele F, Schols L (2011) Mutations in the PDYN gene (SCA23) are not a frequent cause of dominant ataxia in Central Europe. Clin Genet 80(5):503–504. doi:10.1111/j.1399-0004.2011.01651.x
Fogel BL, Lee JY, Lane J, Wahnich A, Chan S, Huang A, Osborn GE, Klein E, Mamah C, Perlman S, Geschwind DH, Coppola G (2012) Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia. Mov Disord 27(3):442–446. doi:10.1002/mds.24064
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676. doi:10.1212/01.wnl.0000324625.00404.15
Garcia-Arocena D, Hagerman PJ (2010) Advances in understanding the molecular basis of FXTAS. Hum Mol Genet 19 (R1):R83–89. doi:10.1093/hmg/ddq166
Wang JL, Yang X, Xia K, Hu ZM, Weng L, Jin X, Jiang H, Zhang P, Shen L, Guo JF, Li N, Li YR, Lei LF, Zhou J, Du J, Zhou YF, Pan Q, Wang J, Li RQ, Tang BS (2010) TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain 133(Pt 12):3510–3518. doi:10.1093/brain/awq323
Zemaitaitis MO, Kim SY, Halverson RA, Troncoso JC, Lee JM, Muma NA (2003) Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. J Neuropathol Exp Neurol 62(2):173–184
Zemaitaitis MO, Lee JM, Troncoso JC, Muma NA (2000) Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol 59(11):983–989
Acknowledgments
The authors wish to thank all the patients and their families who contributed to this project. Study support provided by NIMH K08MH86297 (BLF) and the UCLA Program in Neurogenetics (BLF).
Conflicts of interest
None relevant to this work declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fogel, B.L., Baker, C., Curnow, A. et al. Mutations in PDYN are not responsible for multiple system atrophy. J Neurol 260, 927–928 (2013). https://doi.org/10.1007/s00415-012-6830-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-012-6830-x